408 related articles for article (PubMed ID: 9346488)
21. Quercetin Completely Ameliorates Hypoxia-Reoxygenation-Induced Pathophysiology Severity in NY1DD Transgenic Sickle Mice: Intrinsic Mild Steady State Pathophysiology of the Disease in NY1DD Is Also Reversed.
Thangaswamy S; Branch CA; Ambadipudi K; Acharya SA
Biomolecules; 2021 Oct; 11(10):. PubMed ID: 34680105
[TBL] [Abstract][Full Text] [Related]
22. High oxygen environment during pregnancy rescues sickle cell anemia mice from prenatal death.
Ye L; Chang JC; Lu R; Kan YW
Blood Cells Mol Dis; 2008; 41(1):67-72. PubMed ID: 18207438
[TBL] [Abstract][Full Text] [Related]
23. Towards a transgenic mouse model of sickle cell disease: hemoglobin SAD.
Trudel M; Saadane N; Garel MC; Bardakdjian-Michau J; Blouquit Y; Guerquin-Kern JL; Rouyer-Fessard P; Vidaud D; Pachnis A; Roméo PH
EMBO J; 1991 Nov; 10(11):3157-65. PubMed ID: 1915288
[TBL] [Abstract][Full Text] [Related]
24. High expression of human beta S- and alpha-globins in transgenic mice: hemoglobin composition and hematological consequences.
Fabry ME; Nagel RL; Pachnis A; Suzuka SM; Costantini F
Proc Natl Acad Sci U S A; 1992 Dec; 89(24):12150-4. PubMed ID: 1465454
[TBL] [Abstract][Full Text] [Related]
25. Introduction and expression of the human Bs-globin gene in transgenic mice.
Rubin EM; Lu RH; Cooper S; Mohandas N; Kan YW
Am J Hum Genet; 1988 Apr; 42(4):585-91. PubMed ID: 3348218
[TBL] [Abstract][Full Text] [Related]
26. Murine glutathione S-transferase A1-1 in sickle transgenic mice.
Ginzburg YZ; Andorfer JH; Rybicki AC; Fabry ME; Nagel RL
Am J Hematol; 2007 Oct; 82(10):911-5. PubMed ID: 17617791
[TBL] [Abstract][Full Text] [Related]
27. Lessons from transgenic mouse lines expressing sickle hemoglobin.
Nagel RL
Proc Soc Exp Biol Med; 1994 Apr; 205(4):274-81. PubMed ID: 8171050
[No Abstract] [Full Text] [Related]
28. Sequence of the -530 region of the beta-globin gene of sickle cell anemia patients with the Arabian haplotype.
Zeng FY; Rodgers GP; Huang SZ; Schechter AN; Salamah M; Perrine S; Berg PE
Hum Mutat; 1994; 3(2):163-5. PubMed ID: 8199597
[No Abstract] [Full Text] [Related]
29. Transgenic mice expressing human sickle hemoglobin are partially resistant to rodent malaria.
Shear HL; Roth EF; Fabry ME; Costantini FD; Pachnis A; Hood A; Nagel RL
Blood; 1993 Jan; 81(1):222-6. PubMed ID: 8417791
[TBL] [Abstract][Full Text] [Related]
30. Red blood cell membrane and density changes under ambient and hypoxic conditions in transgenic mice producing human sickle hemoglobin.
Reilly MP; Chomo MJ; Obata K; Asakura T
Exp Hematol; 1994 Jun; 22(6):501-9. PubMed ID: 8187846
[TBL] [Abstract][Full Text] [Related]
31. Sickle hemoglobin (HbS) allele and sickle cell disease: a HuGE review.
Ashley-Koch A; Yang Q; Olney RS
Am J Epidemiol; 2000 May; 151(9):839-45. PubMed ID: 10791557
[TBL] [Abstract][Full Text] [Related]
32. Direct identification of sickle cell anemia by blot hybridization.
Geever RF; Wilson LB; Nallaseth FS; Milner PF; Bittner M; Wilson JT
Proc Natl Acad Sci U S A; 1981 Aug; 78(8):5081-5. PubMed ID: 6272289
[TBL] [Abstract][Full Text] [Related]
33. Pain-related behaviors and neurochemical alterations in mice expressing sickle hemoglobin: modulation by cannabinoids.
Kohli DR; Li Y; Khasabov SG; Gupta P; Kehl LJ; Ericson ME; Nguyen J; Gupta V; Hebbel RP; Simone DA; Gupta K
Blood; 2010 Jul; 116(3):456-65. PubMed ID: 20304807
[TBL] [Abstract][Full Text] [Related]
34. Retroviral transfer of a human beta-globin/delta-globin hybrid gene linked to beta locus control region hypersensitive site 2 aimed at the gene therapy of sickle cell disease.
Takekoshi KJ; Oh YH; Westerman KW; London IM; Leboulch P
Proc Natl Acad Sci U S A; 1995 Mar; 92(7):3014-8. PubMed ID: 7708766
[TBL] [Abstract][Full Text] [Related]
35. Towards a mouse model for sickle cell disease: HB SAD.
Trudel M; Garel MC; Saadane N; Rouyer-Fessard P; Vidaud D; Costantini F; Beuzard Y
Nouv Rev Fr Hematol (1978); 1990; 32(6):407-8. PubMed ID: 2101873
[TBL] [Abstract][Full Text] [Related]
36. Alpha-thalassemia in blacks: genetic and clinical aspects and interactions with the sickle hemoglobin gene.
Steinberg MH; Embury SH
Blood; 1986 Nov; 68(5):985-90. PubMed ID: 3533181
[TBL] [Abstract][Full Text] [Related]
37. Overview of pathophysiology and rationale for treatment of sickle cell anemia.
Rodgers GP
Semin Hematol; 1997 Jul; 34(3 Suppl 3):2-7. PubMed ID: 9317195
[TBL] [Abstract][Full Text] [Related]
38. Limitations of a mouse model of sickle cell anemia.
Ieremia J; Blau CA
Blood Cells Mol Dis; 2002; 28(2):146-51. PubMed ID: 12064910
[TBL] [Abstract][Full Text] [Related]
39. 5-Azacytidine increases fetal hemoglobin production in a patient with sickle cell disease.
Dover GJ; Charache SH; Boyer SH; Talbot CC; Smith KD
Prog Clin Biol Res; 1983; 134():475-88. PubMed ID: 6198661
[TBL] [Abstract][Full Text] [Related]
40. High expression of human beta S- and alpha-globins in transgenic mice: erythrocyte abnormalities, organ damage, and the effect of hypoxia.
Fabry ME; Costantini F; Pachnis A; Suzuka SM; Bank N; Aynedjian HS; Factor SM; Nagel RL
Proc Natl Acad Sci U S A; 1992 Dec; 89(24):12155-9. PubMed ID: 1465455
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
